Bavna Saluja

Bavna Saluja is an accomplished professional in the field of regulatory science with extensive experience in leading regulatory strategies for pharmaceutical companies. Currently serving as the Global Regulatory Lead for Immunology and Neuroscience at Eli Lilly and Company, a role held since April 2023, Bavna has previously held significant positions such as Director of Global Regulatory Strategy at Otsuka Pharmaceutical Companies (U.S.) and Associate Director for Therapeutic Review at the FDA. With expertise developed through roles like Acting Deputy Director of the Division of Inflammation and Immune Pharmacology and Team Lead in the Office of Clinical Pharmacology at the FDA, along with an early research role at Dr. Reddy's Laboratories, Bavna brings a rich background to the regulatory landscape. Bavna holds a Doctor of Philosophy in Pharmaceutical Sciences from Virginia Commonwealth University and a Master of Science in Pharmaceutics and Drug Design from Delhi University.